{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:50:58Z","timestamp":1785372658386,"version":"3.55.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T00:00:00Z","timestamp":1551916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000406","name":"Motor Neurone Disease Association","doi-asserted-by":"publisher","award":["Hafezparast\/Apr15\/836-791"],"award-info":[{"award-number":["Hafezparast\/Apr15\/836-791"]}],"id":[{"id":"10.13039\/501100000406","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000406","name":"Motor Neurone Disease Association","doi-asserted-by":"publisher","award":["Hafezparast\/Apr18\/861-791"],"award-info":[{"award-number":["Hafezparast\/Apr18\/861-791"]}],"id":[{"id":"10.13039\/501100000406","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/P021042\/1"],"award-info":[{"award-number":["BB\/P021042\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.00186","type":"journal-article","created":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T04:23:16Z","timestamp":1551932596000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":72,"title":["An Overview of MicroRNAs as Biomarkers of ALS"],"prefix":"10.3389","volume":"10","author":[{"given":"Greig","family":"Joilin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Nigel","family":"Leigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah F.","family":"Newbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Hafezparast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"371","DOI":"10.12688\/f1000research.10476.1","article-title":"What causes amyotrophic lateral sclerosis?","volume":"6","author":"Martin","year":"2017","journal-title":"F1000Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s10571-013-9940-9","article-title":"Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases","volume":"33","author":"Jin","year":"2013","journal-title":"Cell Mol Neurobiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/2051-5960-1-42","article-title":"Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis","volume":"1","author":"Freischmidt","year":"2013","journal-title":"Acta Neuropathol Commun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10048-014-0420-2","article-title":"miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients","volume":"15","author":"De Felice","year":"2014","journal-title":"Neurogenetics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1093\/brain\/awu249","article-title":"Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre-manifest mutation carriers","volume":"137","author":"Freischmidt","year":"2014","journal-title":"Brain"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e89065","DOI":"10.1371\/journal.pone.0089065","article-title":"MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis","volume":"9","author":"Toivonen","year":"2014","journal-title":"PLoS ONE"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2660.e2615","DOI":"10.1016\/j.neurobiolaging.2015.06.003","article-title":"Serum microRNAs in sporadic amyotrophic lateral sclerosis","volume":"36","author":"Freischmidt","year":"2015","journal-title":"Neurobiol Aging"},{"key":"B9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13041-015-0161-7","article-title":"Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis","volume":"8","author":"Takahashi","year":"2015","journal-title":"Mol Brain"},{"key":"B10","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s12017-016-8396-8","article-title":"Identification of miRNAs as potential biomarkers in cerebrospinal fluid from amyotrophic lateral sclerosis patients","volume":"18","author":"Benigni","year":"2016","journal-title":"Neuromolecular Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jns.2016.06.046","article-title":"MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis","volume":"368","author":"de Andrade","year":"2016","journal-title":"J Neurol Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13195-017-0316-0","article-title":"Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases","volume":"9","author":"Sheinerman","year":"2017","journal-title":"Alzheimers Res Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neurobiolaging.2017.03.027","article-title":"Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS)","volume":"55","author":"Waller","year":"2017","journal-title":"Neurobiol Aging"},{"key":"B14","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3389\/fnins.2017.00731","article-title":"Small RNA sequencing of sporadic amyotrophic lateral sclerosis cerebrospinal fluid reveals differentially expressed miRNAs related to neural and glial activity","volume":"11","author":"Waller","year":"2017","journal-title":"Front Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fnmol.2018.00288","article-title":"Dysregulation of microRNAs and target genes networks in peripheral blood of patients with sporadic amyotrophic lateral sclerosis","volume":"11","author":"Liguori","year":"2018","journal-title":"Front Mol Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neurobiolaging.2017.12.020","article-title":"Genome-wide circulating microRNA expression profiling reveals potential biomarkers for amyotrophic lateral sclerosis","volume":"64","author":"Matamala","year":"2018","journal-title":"Neurobiol Aging"},{"key":"B17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/mus.26106","article-title":"Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis","volume":"58","author":"Raheja","year":"2018","journal-title":"Muscle Nerve"},{"key":"B18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5582\/irdr.2017.01091","article-title":"Comparison of the extraction and determination of serum exosome and miRNA in serum and the detection of miR-27a-3p in serum exosome of ALS patients","volume":"7","author":"Xu","year":"2018","journal-title":"Intractable Rare Dis Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"8361237","DOI":"10.1155\/2017\/8361237","article-title":"Serum miRNAs miR-23a, 206, and 499 as potential biomarkers for skeletal muscle atrophy","volume":"2017","author":"Wang","year":"2017","journal-title":"Biomed Res Int."},{"key":"B20","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s12199-014-0405-7","article-title":"Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy","volume":"19","author":"Matsuzaka","year":"2014","journal-title":"Environ Health Prev Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.molmed.2017.09.002","article-title":"Biomarker potential of extracellular miRNAs in duchenne muscular dystrophy","volume":"23","author":"Coenen-Stass","year":"2017","journal-title":"Trends Mol Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.nbd.2018.02.009","article-title":"Muscle microRNA signatures as biomarkers of disease progression in amyotrophic lateral sclerosis","volume":"114","author":"Si","year":"2018","journal-title":"Neurobiol Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"23743","DOI":"10.3402\/jev.v3.23743","article-title":"Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood","volume":"3","author":"Cheng","year":"2014","journal-title":"J Extracell Vesicles"},{"key":"B24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12920-015-0109-x","article-title":"Biomarker discovery: quantification of microRNAs and other small non-coding RNAs using next generation sequencing","volume":"8","author":"Lopez","year":"2015","journal-title":"BMC Med Genomics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/15476286.2017.1403003","article-title":"A comprehensive profile of circulating RNAs in human serum","volume":"15","author":"Umu","year":"2018","journal-title":"RNA Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.joca.2012.08.016","article-title":"Serum non-coding RNAs as biomarkers for osteoarthritis progression after ACL injury","volume":"20","author":"Zhang","year":"2012","journal-title":"Osteoarthr Cartil."},{"key":"B27","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.21873\/anticanres.11239","article-title":"Expression levels of PIWI-interacting RNA, piR-823, are deregulated in tumor tissue, blood serum and urine of patients with renal cell carcinoma","volume":"36","author":"Iliev","year":"2016","journal-title":"Anticancer Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"43558","DOI":"10.1038\/srep43558","article-title":"Serum snoRNAs as biomarkers for joint ageing and post traumatic osteoarthritis","volume":"7","author":"Steinbusch","year":"2017","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1038\/s41598-018-21604-6","article-title":"Early detection of preeclampsia using circulating small non-coding RNA","volume":"8","author":"Yoffe","year":"2018","journal-title":"Sci Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/1476-4598-9-198","article-title":"Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer","volume":"9","author":"Liao","year":"2010","journal-title":"Mol Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12943-016-0520-8","article-title":"Small non-coding RNA biomarkers in sputum for lung cancer diagnosis","volume":"15","author":"Su","year":"2016","journal-title":"Mol Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1261\/rna.058834.116","article-title":"Identification of urinary exosomal noncoding RNAs as novel biomarkers in chronic kidney disease","volume":"23","author":"Khurana","year":"2017","journal-title":"RNA"},{"key":"B33","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1373\/clinchem.2010.157198","article-title":"Analysis of circulating microRNA: preanalytical and analytical challenges","volume":"57","author":"McDonald","year":"2011","journal-title":"Clin Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fgene.2013.00094","article-title":"The impact of hemolysis on cell-free microRNA biomarkers","volume":"4","author":"Kirschner","year":"2013","journal-title":"Front Genet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/jcmm.12236","article-title":"Methodological challenges in utilizing miRNAs as circulating biomarkers","volume":"18","author":"Moldovan","year":"2014","journal-title":"J Cell Mol Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/biom8020021","article-title":"Circulating microRNA biomarkers in melanoma: tools and challenges in personalised medicine","volume":"8","author":"Mumford","year":"2018","journal-title":"Biomolecules"},{"key":"B37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neulet.2012.03.062","article-title":"MicroRNAs miR-144\/144* and miR-16 in peripheral blood are potential biomarkers for naturalistic stress in healthy Japanese medical students","volume":"516","author":"Katsuura","year":"2012","journal-title":"Neurosci Lett."},{"key":"B38","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1158\/1940-6207.CAPR-11-0370","article-title":"Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies","volume":"5","author":"Pritchard","year":"2012","journal-title":"Cancer Prev Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"28006","DOI":"10.1038\/srep28006","article-title":"Circulating plasma microRNAs can differentiate human sepsis and Systemic Inflammatory Response Syndrome (SIRS)","volume":"6","author":"Caserta","year":"2016","journal-title":"Sci Rep"}],"updated-by":[{"DOI":"10.3389\/fneur.2019.01129","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:00:00Z","timestamp":1571788800000}}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00186\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T09:09:55Z","timestamp":1571994595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00186\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,7]]},"references-count":39,"alternative-id":["10.3389\/fneur.2019.00186"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.00186","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fneur.2019.01129","asserted-by":"object"}]},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,7]]},"article-number":"186"}}